影响维持性血液透析患者甲状旁腺素水平的相关因素分析被引量：12

在线阅读下载PDF

导出

摘要继发性甲状旁腺功能亢进（SHPT）是慢性肾功能衰竭的常见并发症之一。随着血液透析和腹膜透析2种肾脏替代治疗模式的发展,尿毒症患者的生存期延长,SHPT的发病率也有所增加。甲状旁腺素（PTH）作为一种尿毒症毒素也日益引起人们关注，它不但是SHPT的标志，而且可以引起多种器官损伤。有人认为，高PTH血症可解释几乎全部尿毒症症状。本文回顾性分析2008年10月在我院透析中心行规律维持性血液透析（MHD）的111例患者的全段甲状旁腺激素（iPTH）水平、各项生化指标及临床资料，报告如下。

作者李春红田洁王洪玲袁萍

机构地区天津医科大学三中心临床学院

出处《天津医药》 CAS 北大核心 2010年第3期234-235,共2页 Tianjin Medical Journal

关键词甲状旁腺素肾透析尿毒症甲状旁腺功能亢进症继发性

分类号 R459.5 [医药卫生—治疗学]

引文网络
相关文献

参考文献7

1徐元钊,林善琰.慢性肾功能衰竭[M].见:陈灏珠主编,实用内科学.第10版.北京:人民卫生出版社,1997:1755-1764.
2卞维静,王国勤,罗洋,付芳婷,张凌,李文歌,谌贻璞.长期血液透析患者继发性甲状旁腺功能亢进症的流行病学分析[J].中日友好医院学报,2008,22(4):195-197. 被引量：37
3Brown EM,MacLeod RJ.Extracellular calcium sensing and extracellular calcium signaling[J].Physiol Rev,2001,81(6):239-297.
4Malberti F,Marcelli D,Conie F,et al.Parathyroidectomy inpatients on renal replacement therapy:an epidemiologic study[J].AM Soc Nephrol,2001,12(10):1242-1248.
5钱家麒.关注血液透析中若干问题,进一步提高血液透析治疗水平[J].中华肾脏病杂志,2005,21(2):63-64. 被引量：30
6甘良英,王梅,杨镜华,檀敏,谈一意,张大伟.维持性血液透析患者脉压及相关因素分析[J].中国血液净化,2008,7(6):300-302. 被引量：3
7London GM,Marchais SJ,Guerin AP.Arterial structure and function in end-stage renal disease[J].Nephrol Dial Transplant,2002,17(10):1713-1724.

二级参考文献29

1孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报（医学版）,2005,37(2):147-150. 被引量：63
2周福德,王梅.北京市血液透析的发展与质量改进[J].中国血液净化,2006,5(3):117-118. 被引量：56
3Foley RN,Parfrey PS,Harnett JD,et al.Impact of hypertension on cardiomyopathy,morbidity and mortality in end-stage renal disease[J].Kidney Int,1996,49:1379-1385.
4Iseki K,FukiyamaK.Predictors of stroke in patients receiving chronic hemodialysis[J].Kidney Int,1996,50:1672-1675.
5Blather J,Staessen JA,Girerd X,et al.Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients[J].Arch Intern Med,2000,160:1085-1089.
6Chae CU,Pfeffer MA,Glynn RJ,et al.Increased pulse pressure and risk of heart failure in the elderly[J].JAMA,1999,281:634-639.
7Mitchell GF,Moye LA,Braunwald E,et al.Sphygmomanumetrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function.SAVE investigators.Survival and Ventricular Enlargement[J].Circulation,1997,96:4254-4260.
8Foley RN,Parfrey PS,Sarnak MJ.Clinical epidemiology of cardiovascular disease in chronic renal disease[J].Am J Kidney Dis,1998,32:Sl12-S119.
9Tozawa M,Iseki K,Iseki C,et al.Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis[J].Kidney Int,2002,61:717-726.
10Foucan L,Deloumeanx J,Hue K et al.High pulse pressure associated with cardiovascular events in patients with type 2 diabetes undergoing hemodialysis[J].Am J Hypertens,2005,18:1457-1462.